Prime

Brazil stands by malaria drug despite WHO suspension

Hydroxychloroquine, the malaria drug whose clinical trials as a potential treatment for Covid-19 have been suspended by WHO. Brazil's health ministry said on May 25, 2020 that it would not change its recommendation to treat coronavirus with hydroxychloroquine. PHOTO | GEORGE FREY | AFP

By  AFP

Brasília,

Brazil's health ministry said Monday it would not change its recommendation to treat coronavirus with hydroxychloroquine, despite the World Health Organisation (WHO) deciding to suspend trials of the drug over safety concerns.

Be the First to Know

Get the stories shaping East Africa — delivered straight to your inbox

Conflict

  1. Explainer: Why new war in Ethiopia’s Tigray threatens to trigger wider conflict

  2. Ethiopia, Sudan junta bicker again over RSF support claims

  3. East Africa’s oil rivalry is missing the bigger energy security question

  4. PRIME Why US proposal to expand Sudan arms embargo is stirring debate

Latest

  1. PRIME Mwakinyo: I never loved boxing, but it saved my family

  2. PRIME Somalia, Somaliland leaders seek US attention at UN meet

  3. PRIME 'Resident Evil' 2026: The adaptation that Hollywood got right

  4. PRIME Ethiopia accuses ‘external actors’ of fuelling conflict

In the headlines

View All